Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
CYP2C8 encodes a member of the cytochrome P450 superfamily of enzymes. De plus, nous expédions CYP2C8 Protéines (3) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 51 products:
Human Polyclonal CYP2C8 Primary Antibody pour ELISA, WB - ABIN4302095
Leskelä, Jara, Leandro-García, Martínez, García-Donas, Hernando, Hurtado, Vicario, Montero-Conde, Landa, López-Jiménez, Cascón, Milne, Robledo, Rodríguez-Antona: Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. dans The pharmacogenomics journal 2011
review summarizes glucuronides as CYP2C8 ligands and the active-site structural features of CYP2C8 that allow potential binding to glucuronides
Preliminary results demonstrate SNPs in CYP2C8 represent potential genetic markers of coronary heart disease susceptibility.
Inhibition of CYP2C8 activity adds to the protective effects of omega-3 LCPUFA on pathological retinal neovascularization and choroidal neovascularization.
CYP2C8*3 carriers had an increased risk of peripheral neuropathy
CYP2C8 Variants are associated with Ischemic Stroke.
This review focuses on recent findings of in vitro studies on drug metabolizing activity of 3 highly polymorphic CYP2C (Montrer CYP2C19 Anticorps) members: CYP2C8, CYP2C9 (Montrer CYP2C9 Anticorps), and CYP2C19 (Montrer CYP2C19 Anticorps).
CYP2C8*3 is a gain-of-function polymorphism for imatinib N-demethylation, which appears to be mainly mediated by CYP2C8 and not CYP3A4 (Montrer CYP3A4 Anticorps) in vitro in human liver microsomes
CYP2C8 genetic polymorphisms may influence outcome of taxane therapy in Roma and Hungarian populations.
CYP2C8-derived epoxyeicosatrienoic acids prevented TNF-alpha (Montrer TNF Anticorps)-induced HUVECs apoptosis via inhibition of oxidative stress associated with the Nrf2 (Montrer GABPA Anticorps) signaling.
Interaction among CYP2C8, EPHX2 (Montrer EPHX2 Anticorps), and CYP4A11 (Montrer CYP4A11 Anticorps) Gene Variants Significantly Increases the Risk for Ischemic Stroke.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene.
cytochrome P450 2C8
, cytochrome P450 CYP2C74
, Cytochrome P450 2C8
, cytochrome P450, family 2, subfamily C, polypeptide 8
, P450 form 1
, cytochrome P450 IIC2
, cytochrome P450 MP-12
, cytochrome P450 MP-20
, cytochrome P450 form 1
, cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 8
, flavoprotein-linked monooxygenase
, microsomal monooxygenase
, s-mephenytoin 4-hydroxylase
, xenobiotic monooxygenase